Amoéba
Develops natural microbiological solutions to manage bacterial and fungal risks.
ALMIB | PA
Overview
Corporate Details
- ISIN(s):
- FR0011051598 (+2 more)
- LEI:
- 9695005QNE7C8Z0LXU64
- Country:
- France
- Address:
- 38 AVENUE DES FRERES MONTGOLFIER, 69680 CHASSIEU
- Website:
- https://amoeba-nature.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other chemical products
Description
Amoéba is a biotechnology company that develops natural microbiological solutions for managing bacterial and fungal risks. The company's core technology is based on the patented use of the amoeba *Willaertia magna* C2c Maky and its biocidal properties. Its primary focus is on agricultural biocontrol, offering a biofungicide derived from a mechanically lysed amoeba. This product targets plant diseases such as mildews, rusts, and powdery mildew, providing a biological alternative to chemical treatments. Amoéba has also developed applications for its technology in the treatment of bacterial risk in industrial water systems, on surfaces, and for chronic wounds.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2019-04-25 17:45 |
AMOÉBA announces the availability of its 2018 Registration Document including t…
|
English | PDF • 116.8 KB | ||
| 2019-04-15 17:45 |
AMOEBA annonce l’émission de la quatrième tranche de 26 obligations convertible…
|
French | PDF • 194.7 KB | ||
| 2019-04-15 17:45 |
AMOEBA announces the issuance of the fourth tranche of 26 bonds convertible int…
|
English | PDF • 163.5 KB | ||
| 2019-04-03 17:40 |
Amoeba : Nombre total de droits de vote et d'actions composant le capital au 31…
|
French | PDF • 121.8 KB | ||
| 2019-03-22 16:40 |
Des résultats annuels 2018 en ligne avec le repositionnement de la Société
|
French | PDF • 224.4 KB | ||
| 2019-03-22 16:40 |
2018 annual results in line with the Company's repositioning
|
English | PDF • 183.0 KB | ||
| 2019-03-18 17:40 |
AMOEBA annonce l’émission de la troisième tranche de 26 obligations convertible…
|
French | PDF • 180.5 KB | ||
| 2019-03-18 17:40 |
AMOEBA announces the issuance of the third tranche of 26 bonds convertible into…
|
English | PDF • 150.8 KB | ||
| 2019-03-12 15:32 |
Franchissement de seuils
|
French | PDF • 20.8 KB | ||
| 2019-03-08 10:44 |
Déclaration du nombre total de droits de vote et du nombre d’actions composant …
|
French | PDF • 122.1 KB | ||
| 2019-03-07 17:40 |
AMOEBA annonce que sa substance active a une action élicitrice sur la vigne et …
|
French | PDF • 120.5 KB | ||
| 2019-03-07 17:40 |
AMOEBA announces that its active substance has an eliciting action on the vine …
|
English | PDF • 108.1 KB | ||
| 2019-02-25 17:40 |
Amoeba annonce que Malte a accepté d’être évaluateur de la nouvelle demande d’a…
|
French | PDF • 142.6 KB | ||
| 2019-02-25 17:40 |
Amoeba announces that Malta has agreed to be the reviewer of the new applicati…
|
English | PDF • 112.8 KB | ||
| 2019-02-15 17:45 |
AMOEBA annonce l’émission de la deuxième tranche de 26 obligations convertibles…
|
French | PDF • 180.6 KB |
Automate Your Workflow. Get a real-time feed of all Amoéba filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Amoéba
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Amoéba via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-30 | N/A | Other | Buy | 6,300 | 3,609.90 EUR |
| 2024-08-29 | N/A | Other | Sell | 5,500 | 3,564.00 EUR |
| 2024-08-28 | N/A | Other | Buy | 3,200 | 1,782.08 EUR |
| 2024-08-27 | N/A | Other | Buy | 20,049 | 11,231.45 EUR |
| 2024-08-26 | N/A | Other | Buy | 31,107 | 17,441.69 EUR |
| 2024-08-22 | N/A | Other | Buy | 2,255 | 1,298.88 EUR |
| 2024-08-20 | N/A | Other | Buy | 16,664 | 8,838.59 EUR |
| 2024-08-19 | N/A | Other | Buy | 13,390 | 6,795.43 EUR |
| 2024-08-16 | N/A | Other | Buy | 6,745 | 3,468.28 EUR |
| 2024-08-09 | N/A | Other | Buy | 40,748 | 21,559.77 EUR |
Peer Companies
